Florida Board of Pharmacy

This program meets the requirements outlined in Section 465.1895 , Florida Statutes for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician in the State of Florida. Upon successful completion of the program, participants will earn a certificate of achievement from the University of Florida Office of Continuing Pharmacy Education.

This certificate training program focuses on topics related to collaborative practice agreements between pharmacists and physicians. This program will expand upon content included in the initial Collaborative Practice Agreement Program program.

This program is intended for pharmacists seeking to become a Florida licensed consultant pharmacist. This course will provide insight into regulatory requirements and clinical knowledge necessary to practice as a consultant pharmacist in the state of Florida.

This program is intended for licensed consultant pharmacists seeking continuing education for licensure renewal. This course will provide a review of regulatory requirements and clinical knowledge necessary to practice as a consultant pharmacist in the state of Florida.

The Pharmacy-based Test and Treat certificate training program is a practice-based curriculum based on national educational standards that prepares pharmacists to provide point-of-care testing (POCT) and diagnostic services for minor, nonchronic health conditions that can be managed with minimal treatment or self-care. 

This Pharmacy-Based Test and Treat Recertification Course focuses on topics related to point-of-care testing and treatment for minor, non-chronic disease states between pharmacists and physicians in the state of Florida.

This certificate training program will prepare pharmacists with comprehensive knowledge, skills, and resources necessary to provide immunization services to patients across the life span.

This course is designed as a resource to help prepare the pharmacist for the responsibility of monitoring and managing anticoagulation therapy patients and clinics. It is also designed to serve as a starting point to help the pharmacist prepare for the Certified Anticoagulation Care Provider (CACP) exam. This program is approved by the Florida Board of Pharmacy for consultant pharmacist recertification credit.

This program is designed to equip the pharmacist with the knowledge necessary to implement pharmacogenomics into clinical practice in a variety of settings. Leading experts in the field of pharmacogenomics will provide educational content focusing on the following: background of pharmacogenomics, aspects of pharmacogenomic testing (laboratory considerations and interpretation of results), clinical implications of pharmacogenomics in multiple disease states including cardiology, oncology, pain management, and psychiatry, and adverse drug reactions (ADRs).

This program will identify the role of the pharmacist in ambulatory care settings, explore the importance of incorporating evidence-based practice into patient care, and review the treatment and management of various health conditions managed in the ambulatory care setting.

This program seeks to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act to provide training on the treatment and management of patients with opioid or other substance abuse disorders.

This activity will provide an overview of the medications used in the treatment of HIV. Specifically, discussed will be the different classes of antiretrovirals, including the mechanism of action, common side effects, drug-drug interactions, and limitations or special considerations which are unique to specific agents.

This program will provide an introduction address current treatment regimens, individual and community-level prevention and treatment of youth living with HIV/AIDS, and opportunities and barriers for inclusion of youth in HIV/AIDS clinical trials. Additionally, we will review Florida law as it pertains to HIV testing, including partner notification, privilege to warn, and testing in pregnant women.

This continuing Education program will provide guidance to practicing pharmacists and pharmacy technicians on the recognition of human trafficking and what subsequent action steps can be taken to best support victims of trafficking.

The validation, dispensing, and counseling of controlled substances by pharmacists is a critical intervention point for resisting opioid misuse and ensuring safe and effective healthcare for the public. This course is approved by the Florida Board of Pharmacy to fulfill the medication errors licensure renewal requirements outlined in Rule 64B16-26.103.

Pharmacists and pharmacy technicians are key members of the healthcare team who should understand the risks of medication errors and strategies to prevent them. This course is approved by the Florida Board of Pharmacy to fulfill the medication errors licensure renewal requirements outlined in Rule 64B16-26.103.

Review the treatment and management of various infectious diseases that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed. 

Review the treatment and management of various endocrinology and bone health conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed.

Review the treatment and management of various pulmonary conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed. 

This CPE program will review the treatment and management of various cardiology health conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed.

This CPE program will introduce the participant to the assessment and management of acute pain. This program will be given in two parts. Part 1 will focus on acute non-surgical pain while Part 2 will focus on acute surgical pain and patient controlled analgesia. This program will provide the consultant pharmacist with knowledge and skill in the selection of drug therapy and recommend appropriate efficacy and safety monitoring for both opioid and non-opioid therapies used in the management of both acute non-surgical and surgical pain.   

The goal of this program is to review these conditions and their treatments so as to better understand how they fit into the overall risk picture for metabolic syndrome. Learners will successfully view recorded lecture content available online via an online Learning Management System, complete required readings, and assessment activities for a total of 6.0 hours of CPE.

The course is intended to provide the legal framework for regulation of HDS, what potential quality indicators can be used to make informed recommendations for use, and adequate communication with patients to avoid or reduce the risk of drug interactions with concomitant HDS use.

The purpose of this course is to provide the pharmacist with an overview of motivational interviewing terms and techniques as a communication and counseling approach designed to help patients find their own motivation to make a positive change in their behavior.

This course will update the pharmacist in the prevention and management of infectious diseases and issues that are important to the care of patients in such long-term settings.

The content of this program will provide the pharmacist with a review of thromboembolic risk factors and coagulation disorders. Utilizing current guidelines and recommendations, this program will provide the learner with the tools necessary to provide routine management of anticoagulant therapy in outpatient settings. Key concepts will be reinforced though case applications.

Pharmacists have an important role in providing diabetes management. The content of this program will provide the pharmacist with a review of the pathophysiology of diabetes, oral an injectable diabetes medications and therapeutic plan development. 

During this educational activity, the learner will learn to recognize, treat, and control this chronic condition using patient-centered care.  The learner will have an overview of asthma and will be familiar with patient assessment, the appropriate treatments and correct use of inhalers and devices used in asthma.

This program provides an overview of antibiotic stewardship in hospitals, long-term care and outpatient facilities with the goal of empowering pharmacists to address the growing concern of inappropriate antibiotic use.

This Alzheimer’s disease continuing education course covers pharmacologic and medical therapies, the role of pharmacists in caring for patients with Alzheimer’s, strategies for addressing the effects of the disease, and ways to support families and caregivers.